Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery

Despite many articles regarding the antihemorrhagic treatment and prophylaxis, there is a lack of experience about how to best conduct major surgical procedures in patients with congenital factor XIII (FXIII) deficiency. Here we report a case of surgery (right inguinal hernia, complicated by heavine...

Descripción completa

Detalles Bibliográficos
Autores principales: Sottilotta, Gianluca, Luise, Francesca, Oriana, Vincenzo, Piromalli, Angela, Santacroce, Rosa, Di Lelio, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397991/
https://www.ncbi.nlm.nih.gov/pubmed/30915205
http://dx.doi.org/10.4081/hr.2019.7912
Descripción
Sumario:Despite many articles regarding the antihemorrhagic treatment and prophylaxis, there is a lack of experience about how to best conduct major surgical procedures in patients with congenital factor XIII (FXIII) deficiency. Here we report a case of surgery (right inguinal hernia, complicated by heaviness and pain) performed in a patient with FXIII deficiency, receiving recombinant FXIII prophylaxis (Catridecacog 35 UI/kg every 28±2 days). Our experience shows that Catridecacog can be used safely and effectively not only for continued prophylaxis but also in surgery and adds to the very limited body of evidence currently available on surgery in this bleeding disorder.

Ejemplares similares